Home / Diabetes In Control (page 807)

Diabetes In Control

Cancer Risk with Ezetimibe Is Unlikely Says FDA

The FDA has completed its review of the possible link between ezetimibe (Zetia, Merck/Schering-Plough Pharmaceuticals), the combination of ezetimibe and simvastatin (Vytorin, Merck/Schering-Plough Pharmaceuticals), and an increased risk of cancer and cancer-related deaths. It concludes that the ezetimibe is likely safe.

Read More »

Type 2 Diabetes Gene Predisposes Children to Obesity

Pediatric researchers have found that a gene already implicated in the development of Type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds light on the genetic origins of diabetes and may present an avenue for developing drugs to counteract the disease, which …

Read More »